191 related articles for article (PubMed ID: 9649207)
1. IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice.
Mihara M; Takagi N; Takeda Y; Ohsugi Y
Clin Exp Immunol; 1998 Jun; 112(3):397-402. PubMed ID: 9649207
[TBL] [Abstract][Full Text] [Related]
2. Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice.
Yoshida H; Hashizume M; Suzuki M; Mihara M
Rheumatol Int; 2011 Nov; 31(11):1445-9. PubMed ID: 20473503
[TBL] [Abstract][Full Text] [Related]
3. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
[TBL] [Abstract][Full Text] [Related]
4. Characterization of anti-mouse interleukin-6 receptor antibody.
Okazaki M; Yamada Y; Nishimoto N; Yoshizaki K; Mihara M
Immunol Lett; 2002 Dec; 84(3):231-40. PubMed ID: 12413742
[TBL] [Abstract][Full Text] [Related]
5. Effects of interleukin-6 blockade on the development of autoimmune thyroiditis in nonobese diabetic mice.
Mori K; Yoshida K; Mihara M; Ohsugi Y; Nakagawa Y; Hoshikawa S; Ozaki H; Ito S
Autoimmunity; 2009 Mar; 42(3):228-34. PubMed ID: 19301205
[TBL] [Abstract][Full Text] [Related]
6. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
[TBL] [Abstract][Full Text] [Related]
7. Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB X NZW)F1 hybrid.
Sekigawa I; Ishida Y; Hirose S; Sato H; Shirai T
J Immunol; 1986 Feb; 136(4):1247-52. PubMed ID: 3484766
[TBL] [Abstract][Full Text] [Related]
8. Influences of anti-mouse interleukin-6 receptor antibody on immune responses in mice.
Mihara M; Nishimoto N; Yoshizaki K; Suzuki T
Immunol Lett; 2002 Dec; 84(3):223-9. PubMed ID: 12413741
[TBL] [Abstract][Full Text] [Related]
9. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
[TBL] [Abstract][Full Text] [Related]
10. The effects of interleukin-6 signal blockade on immune system, reproductive and skeletal development in juvenile mice.
Sakurai T; Takai R; Bürgin H; Shioda A; Sakamoto Y; Amano J; Grimm HP; Richter WF; Higuchi Y; Chiba S; Kawamura A; Suzuki M; Müller L
Birth Defects Res B Dev Reprod Toxicol; 2013 Apr; 98(2):170-82. PubMed ID: 23529913
[TBL] [Abstract][Full Text] [Related]
11. The biological response modifier OK-432 (a streptococcal preparation) inhibits the development of autoimmune kidney disease in NZB/W F1 hybrid mice: possible involvement of tumor necrosis factor.
Mihara M; Ohsugi Y
Int Arch Allergy Appl Immunol; 1989; 90(1):37-42. PubMed ID: 2807578
[TBL] [Abstract][Full Text] [Related]
12. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K
BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103
[TBL] [Abstract][Full Text] [Related]
13. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
Sato MN; Minoprio P; Avrameas S; Ternynck T
Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
[TBL] [Abstract][Full Text] [Related]
14. Possible role of IL-6 in pathogenesis of immune complex-mediated glomerulonephritis in NZB/W F1 mice: induction of IgG class anti-DNA autoantibody production.
Mihara M; Ohsugi Y
Int Arch Allergy Appl Immunol; 1990; 93(1):89-92. PubMed ID: 2086490
[TBL] [Abstract][Full Text] [Related]
15. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
[TBL] [Abstract][Full Text] [Related]
16. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid.
Hirose S; Sekigawa I; Ozaki S; Sato H; Shirai T
Clin Exp Immunol; 1984 Dec; 58(3):694-702. PubMed ID: 6334582
[TBL] [Abstract][Full Text] [Related]
17. Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice.
Tomiyama-Hanayama M; Rakugi H; Kohara M; Mima T; Adachi Y; Ohishi M; Katsuya T; Hoshida Y; Aozasa K; Ogihara T; Nishimoto N
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F679-84. PubMed ID: 19570877
[TBL] [Abstract][Full Text] [Related]
18. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
19. Anti-interleukin-6 receptor antibody (MR16-1) promotes muscle regeneration via modulation of gene expressions in infiltrated macrophages.
Fujita R; Kawano F; Ohira T; Nakai N; Shibaguchi T; Nishimoto N; Ohira Y
Biochim Biophys Acta; 2014 Oct; 1840(10):3170-80. PubMed ID: 24440156
[TBL] [Abstract][Full Text] [Related]
20. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
